Kamakura, Japan

Yasuhiro Furuichi

This inventor holds 18 USPTO granted patents and 2 published patent applications and 5 EPO patents, primarily in Cancer Therapeutics. Top assignees: Genecare Research Institute Co., Ltd., Agene Research Institute Co., Ltd., Roche Vitamins Inc.. Active years: 1988-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuhiro Furuichi. Retrieved from https://idiyas.com/inventor/yasuhiro-furuichi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 43(Granted Patents)


Location History:

  • Kanagawa, JP (2002 - 2006)
  • Kamakura, JP (1988 - 2020)

Company Filing History:


Years Active: 1988-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
siRNA
Apoptosis Inducer
Cancer Cell
Chromosome Stabilization
Cell Proliferation Inhibitors
Biotin Biosynthetic Genes
cDNA Synthesis
RecQ4 Gene
Hybridization Carrier
Recombinant Sigma NS Protein
Pharmaceutical Composition
Gene Product
18 patents (USPTO):Explore Patents

Title: Yasuhiro Furuichi: Innovator in Genetic Research

Introduction

Yasuhiro Furuichi is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of genetic research, holding a total of 18 patents. His work focuses on innovative solutions for cancer treatment and genetic engineering.

Latest Patents

Among his latest patents is a modified siRNA and pharmaceutical composition. This invention involves a double-stranded modified siRNA targeting a RecQL1 helicase gene. The sense strand includes specific nucleotide sequences with 2'-substituted nucleotides at various positions. Another notable patent is an apoptosis inducer for cancer cells. This invention reveals that suppressing the expression of certain genes can induce apoptosis in various cancer cells, thereby inhibiting their proliferation.

Career Highlights

Yasuhiro Furuichi has worked with several esteemed organizations, including Genecare Research Institute Co., Ltd. and Agene Research Institute Co., Ltd. His research has paved the way for advancements in cancer therapies and genetic modifications.

Collaborations

He has collaborated with notable colleagues such as Akira Shimamoto and Motoki Takagi. Their combined efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Yasuhiro Furuichi's work exemplifies the impact of innovative research in genetics and cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…